Apresitentan (Tryvio) Discontinuation Precautions: How to Safely Taper Off
Aprocitentan-Tryvio is a new endothelin receptor antagonist mainly used to treat refractory hypertension. This drug is often used as a supplementary option when patients are still unable to achieve ideal blood pressure levels despite treatment with conventional antihypertensive drugs. Since the pharmacological effects of aprecitentan involve vasodilation and the regulation of the endothelin pathway, it is necessary to maintain a stable blood concentration during use to exert a sustained effect. This also determines that discontinuation or reduction of the drug must be gradual to avoid cardiovascular events caused by blood pressure fluctuations.
In actual clinical practice, discontinuation of aprecitentan should not be interrupted suddenly, otherwise it may lead to a rapid rise in blood pressure and even induce the risk of acute stroke or myocardial infarction. If patients need to stop taking the drug, they should gradually reduce the dose under the guidance of a professional doctor, and usually combine it with other antihypertensive drugs to ensure that the blood pressure is maintained at a safe level. In addition, doctors will also develop an individualized drug reduction plan based on the patient's past blood pressure control, concomitant medications, and underlying diseases, such as gradually reducing the dose of aprecitentan while adding diuretics or calcium channel blockers to balance blood pressure control.
During the withdrawal process, patients need to regularly monitor changes in blood pressure. It is best to conduct home blood pressure self-tests and record them so that doctors can adjust treatment strategies in a timely manner. At the same time, patients should pay attention to avoid adverse factors such as high-salt diet, excessive drinking, and mental stress, because these will aggravate blood pressure fluctuations after drug withdrawal. If obvious dizziness, palpitations, chest tightness and other symptoms occur during the medication reduction process, you should seek medical attention immediately to avoid vascular instability caused by stopping the medication too quickly.
In general, discontinuation of aprecitentan is not a simple dose reduction, but a comprehensive medical process that requires a combination of alternative treatments, blood pressure monitoring, and lifestyle intervention. Only by scientifically reducing medication under guidance can the cardiovascular safety of patients be truly guaranteed.
Reference materials:https://go.drugbank.com/drugs/DB15059
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)